Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01168310 · ClinicalTrials.gov registry record · Phase 2
A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2 study, sponsored by Dey.
- Completed
- Registry status
- Phase 2
- Development phase
- 468
- Enrollment target
NCT01168310: Completed Phase 2 study, sponsored by Dey.
NCT01168310 is a Phase 2 study that has completed, run by Dey. The registered enrollment target is 468 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (252% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01168310, a Phase 2 study, has completed, sponsored by Dey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 468 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, multi-dose, parallel group trial which will assess the pharmacodynamic response of fluticasone propionate and formoterol fumarate in subjects with COPD.
Interventions
- DRUG Fluticasone Propionate/Formoterol Fumarate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 468 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
What the finished NCT01168310 record still lists
NCT01168310 is an interventional study that assigns participants to a tested intervention. The registered 468 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (252% higher).
The record links to 0 conditions, and to 1 intervention - of which Fluticasone Propionate/Formoterol Fumarate is the first listed.
NCT01168310 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01168310 about?
NCT01168310 is a clinical study titled "A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)". This is a randomized, double-blind, multi-dose, parallel group trial which will assess the pharmacodynamic response of fluticasone propionate and formoterol fumarate in subjects with COPD.
What is the current status of trial NCT01168310?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 468 participants. The study started on 2010-08. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01168310?
The interventions under investigation include: Fluticasone Propionate/Formoterol Fumarate (DRUG).
Who is sponsoring clinical trial NCT01168310?
This trial is sponsored by Dey, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01168310's enrollment target sits among peer trials
468 80th of 2000 higher than 1,921 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03124303 · 468 participants
Interventions for Postoperative Delirium: Biomarker-3
- NCT03901924 · 468 participants · NA
Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy
- NCT04482309 · 468 participants · Phase 2
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
- NCT05357170 · 468 participants
Microbiome Dysfunction in Surgical Intensive Care Unit Survivors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia